United States · Governance · Issue #3 · 21/09 – 27/09
Three official actions put CPSC governance under closer presidential control
Primary records show three distinct 2025 measures affecting CPSC governance: expanded White House review of independent-agency rules, removal litigation involving three commissioners, and a budget proposal to place CPSC functions within HHS.
What the evidence says
Executive Order 14215, issued on 18 February 2025, required independent regulatory agencies to submit significant proposed and final regulatory actions for OIRA review, directed OMB to set management objectives for independent-agency heads and required closer policy coordination with the Executive Office of the President.
The May removal of three CPSC commissioners produced litigation over the Act's for-cause language and the President's Article II authority. A district court initially restored the commissioners; the Supreme Court stayed that order in July 2025. In June 2026, the Court's merits decision in the separate Trump v. Slaughter case held that officers exercising executive power are generally removable at will.
The FY2026 budget separately proposed placing CPSC functions under an HHS Assistant Secretary, but made the transfer contingent on authorising legislation. Regulatory review, officer removal and statutory reorganisation are different legal mechanisms and should not be collapsed into one claim.
Why it matters
The useful distinction
The practical independence of a safety regulator can be affected through regulatory review, leadership control and institutional design. Evidence-led coverage should identify which mechanism is involved, what has legal effect and what remains only a proposal.
This briefing is an independent summary of the evidence sources below. Context-only links are not used as factual authority. It does not establish that a product, organisation or listing is unsafe, unlawful or non-compliant beyond what the evidence reports.